2023-06-29 09:13:48 ET
- Evelo Biosciences ( NASDAQ: EVLO ) has announced that its Board of Directors has approved a 1-for-20 reverse stock split of the Company’s common stock.
- The reverse stock split will become effective at 5:00 p.m. ET today, June 29, 2023, after close of trading on The Nasdaq.
- The Co.’s common stock is expected to commence trading on a split-adjusted basis when the markets open on June 30, 2023 under the existing trading symbol “EVLO.”
- The reverse stock split will not affect the number of authorized shares of common stock or the par value of the common stock.
- EVLO -19.21% premarket to $0.21.
For further details see:
Evelo Biosciences stock plummets on reverse stock split